Therapeutic method for early-stage second primary non-small lung cancer: Analysis of a population-based database

Early-stage non-small lung cancer patients may survive long enough to develop second primary lung cancers. However, few studies have accurately described the therapeutic method, evaluation or prognostic factors for long-term survival in this complex clinical scenario.